OOIR: Observatory of International Research

Papers

(The H4-Index of Nature Reviews Endocrinology is 61. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
COVID-19 and diabetes mellitus: from pathophysiology to clinical management	677
Exerkines in health, resilience and disease	395
Mitochondrial and metabolic dysfunction in ageing and age-related diseases	394
The burden and risks of emerging complications of diabetes mellitus	392
The role of sugar-sweetened beverages in the global epidemics of obesity and chronic diseases	377
Global pandemics interconnected — obesity, impaired metabolic health and COVID-19	346
Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?)	335
Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics	293
Current understanding of the molecular and cellular pathology of diabetic retinopathy	275
Type 2 diabetes mellitus in older adults: clinical considerations and management	268
The health effects of vitamin D supplementation: evidence from human studies	267
Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus	259
GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease	235
Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy	233
Autophagy in metabolic disease and ageing	213
Endocrine toxicities of immune checkpoint inhibitors	198
Metformin: update on mechanisms of action and repurposing potential	193
Current practice in patients with differentiated thyroid cancer	192
Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver	191
The role of insufficient sleep and circadian misalignment in obesity	178
Environmental factors in declining human fertility	173
Lipid droplet biogenesis and functions in health and disease	153
Clinical application of intermittent fasting for weight loss: progress and future directions	142
Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus	130
Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus	118

Metabolic pathways in obesity-related breast cancer	111
Paracetamol use during pregnancy — a call for precautionary action	109
Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement	109
Macrophage functional diversity in NAFLD — more than inflammation	108
Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations	105
Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD	102
Epigenetic inheritance of polycystic ovary syndrome — challenges and opportunities for treatment	101
The evolving view of thermogenic adipocytes — ontogeny, niche and function	99
The gut microbiota in obesity and weight management: microbes as friends or foe?	95
Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions	92
The importance of the RET gene in thyroid cancer and therapeutic implications	91
International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers	91
Novel therapies with precision mechanisms for type 2 diabetes mellitus	89
Brain insulin signalling in metabolic homeostasis and disease	87
Aggressive pituitary tumours and pituitary carcinomas	80
Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1	80
Assessment and treatment of thyroid disorders in pregnancy and the postpartum period	77
Clinical aspects of multiple endocrine neoplasia type 1	77
Emerging insights into the comparative effectiveness of anabolic therapies for osteoporosis	76
Functions of galanin, spexin and kisspeptin in metabolism, mood and behaviour	76
Metabolic implications of pancreatic fat accumulation	76
The physiological role of β-cell heterogeneity in pancreatic islet function	75
Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus	75
A global view of hypertensive disorders and diabetes mellitus during pregnancy	74
One hundred years of insulin therapy	69
International Consensus Statement on the diagnosis, multidisciplinary management and lifelong care of individuals with achondroplasia	69
Adaptive immune cells shape obesity-associated type 2 diabetes mellitus and less prominent comorbidities	68
The multiple roles of life stress in metabolic disorders	67
Targeting lipid GPCRs to treat type 2 diabetes mellitus — progress and challenges	66
Primary hypothyroidism and quality of life	66
Hormonal regulation of mammary gland development and lactation	66
Cellular and molecular features of EDC exposure: consequences for the GnRH network	65
The role of iron in host–microbiota crosstalk and its effects on systemic glucose metabolism	63
Uterine bleeding: how understanding endometrial physiology underpins menstrual health	61
The G protein-coupled oestrogen receptor GPER in health and disease: an update	61
Hormonal regulation of biomineralization	61
Hepatic sexual dimorphism — implications for non-alcoholic fatty liver disease	61